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Exogenous lipoid pneumonia is a potential problem with any form of oil aspiration. The association of
Mycobacterium fortuitum with lipoid pneumonia is a rare occurrence and ascribed to as yet-unknown
interplay between the oil in the pulmonary parenchyma and the waxy Mycobacterial cell wall. We
describe a case of lipoid pneumonia due to “oil aspiration”, complicated by infection withMycobacterium
fortuitum as well as Nocardia, in an individual with no obvious immune deﬁciencies.
 2010 Published by Elsevier Ltd.1. Introduction
Lipoid pneumonia is a chronic inﬂammatory reaction of the
lungs to the presence of lipid substances. It is of two types, exog-
enous and endogenous. The endogenous variety is due to release of
lipids from lysis of lung tissue on account of tumor, drugs, radiation,
etc. Exogenous lipoid pneumonia results from the aspiration of
vegetable, animal, or most commonly mineral oils. The presence of
a lipoid environment seems to favour Mycobacterium fortuitum
infection. We present such a case with exogenous lipoid pneu-
monia associated with Mycobacterium fortuitum infection super-
added with Nocardia infection.2. Case history
A 60-year-old male presented to the outpatient department
with fever of four days duration, and cough with scanty expecto-
ration. The patient, a non-smoker, had been involved in running
a paper-manufacturing unit until eight years ago. Three years ago
he had been treated for pulmonary tuberculosis of the right middle
lobe (Brock’s syndrome), and he had completed the complete
course of anti-tubercular therapy with good compliance.
One month ago, the patient accidentally drank coconut oil
stored in a drinking water bottle and had a choking episode fol-
lowed by cough that lasted a few days. General examination was
mostly unremarkable, and there was no obvious clubbing or
superﬁcial lymphadenopathy. Physical examination of the chestamy).revealed sparse crackles in the right inframammary area and also
bilaterally in the infrascapular areas.
The total leucocyte count was 16.9  103 (Neutrophils 80%), and
the Erythrocyte Sedimentation Rate (ESR) 60 mm. Human Immu-
nodeﬁciency Virus (HIV) test was negative. The chest radiograph
showed bilateral basal patchy consolidation, muchmore prominent
on the right side (see Fig.1). A Computerized Tomographic (CT) scan
of the chest showed dense consolidation with an airbronchogram
in the right middle lobe and alveolar inﬁltration in left lingula and
both the lower lobes (see Fig. 2). These showed a moderate degree
of heterogenous post-contrast enhancement. Multiple nodular
opacities were also observed in both lungs. Sputum showed acid-
fast bacteria (grade 3þ) on direct staining.
Since it was thought that tuberculosis could not by itself
explain the radiological abnormalitydparticularly the nodular-
itydthe consolidated area was targeted with a CT guided trans-
thoracic needle aspiration. Cytological features of granulomatous
inﬂammation were seen. The stains were positive for fat globules
(see Fig. 3). Acid-fast bacilli were noted, along with the charac-
teristic delicate gram-positive weakly acid-fast ﬁlaments of
Nocardia (see Fig. 4). Culture of both the sputum and the ﬁne-
needle aspirate grew Mycobacterium fortuitum which eventually
showed sensitivity to ethambutol, sparﬂoxacin, oﬂoxacin, cap-
reomycin and amikacindand resistance to streptomycin, iso-
niazide, rifamycin, pyrazinamide and clofazimine.
The patient, who had already been started on the standard four-
drug anti-tubercular therapy plus sulphonamides, was commenced
on oﬂoxacin, amikacin and clarithromycin. Pyrazinamide was
withdrawn. At the end of eighteen months, the patient had shown
complete clinical and radiological recovery (see Fig. 5), and treat-
ment was discontinued.
Fig. 1. Chest radiograph showing right middle lobe consolidation with left mid zonal
inﬁltration.
Fig. 3. Fine needle aspiration cytology of lung showing fat globules (arrows) within
the macrophages.
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Lipoid pneumonia is of two types: endogenous and exogenous.
In the endogenous variety there is lysis of lung tissue distal to an
obstruction by tumor or broncholitis obliterans. Release of lung
lipids can also occur in associationwith chemotherapy, amiodarone
therapy or radiotherapy. Lipid like material is also found in alveolar
proteinosis. Exogenous lipoid pneumonia can occur in a variety of
unusual settings such as in blackfat tobacco smoking seen in
Guyana1 or by exposure to oil mists,2 but it most often occurs in the
setting of medicinal use of liquid parafﬁn for chronic constipation
by accidental aspiration. Oil based nasal drops can also result in
lipoid pneumonia, but these are less commonly used nowadays for
obvious reasons. Mineral oils being relatively inert are less prone to
produce alveolar inﬂammation (this explains the paucity of
symptoms in some individuals) than animal fats (such as in milk:Fig. 2. Computerized tomography of chest in the lung window, showing right middle
lobe consolidation with airbronchogram and left lingular alveolar inﬁltration.these are hydrolysed into fatty acids by lung lipases). Lipases digest
the lung parenchyma and evoke a vigorous inﬂammatory response.
Vegetable oils can be aspirated during feeding or during emesis and
have a highly variable effect. Several individuals have associated
esophageal problems predisposing to aspiration. Lipoid pneumonia
has no characteristic radiologic appearances but a “Parafﬁnoma”
can cast a nodular inﬁltrate chest x-rays or CT ﬁlms, and may
present as a “hot spot” on Positron Emission Tomography (PET)
scans mimicking malignancy.3 The diagnosis must therefore be
suspected in the setting of the appropriate history with radiological
inﬁltration, usually in the basal segments of the lower lobes, the
superior segment of the lower lobe or the posterior segment of an
upper lobe. Bronchoalveolar lavage or lung histopathology will
then usually demonstrate lipid laden foamy macrophages with
occasional giant cells. True granulomas are unusual.
The association of Nontuberculous Mycobacteria (NTM) with
lipoid pneumonia has been noticed. It is intriguing that
Mycobacteria, possessed of the most complex cell wall in nature
(that enabled their survival at the interface of water and soil over
the millenia), appear to derive sustenance from the lipids as in
lipoid pneumonia. This in some way actually appears to increaseFig. 4. Fine needle aspiration cytology of the lung showing weakly acid-fast ﬁlamen-
tous Nocardia (arrow).
Fig. 5. Chest radiograph repeated after completion of treatment showing complete
resolution of the right and left mid zonal lesions.
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enabled labs to organize NTM. Rapidly growing Mycobacteria
(RGM), by deﬁnition grows relatively quickly in culture, and growth
is generally apparent within a week. M. fortuitum the most
commonly found rapid growingMycobacterium in clinical practice,
can cause skin and soft tissue infections, surgical wound infections
and even catheter-related sepsis. Pulmonary disease is relatively
rare.4 This case is one example of the latter, associated with lipoid
pneumonia.
M. fortuitum is generally susceptible to amikacin, ciproﬂoxacin,
oﬂoxacin the sulfonamides, imipenem, clarithromycin, cefoxitin
and to an extent to doxycycline. The resistance of RGM to
conventional anti-tubercular agents has important implications for
therapy. For serious M. fortuitum infection, two parenteral drugs
(Amikacin/Tobramycin, Cefoxitin, Imipenem or Levoﬂoxacin) are
recommended for two to six weeks, plus oral agents (trimetho-
primesulfamethoxazole (TMPeSMX), doxycycline, levoﬂoxacinand
clarithromycin) to which susceptibility is documented. Linezolid
and moxiﬂoxacin may also be useful. Clarithromycin is especially
useful in therapy. For pulmonary disease, treatment must be
continued for a year after conversion of sputum. Surgery is gener-
ally reserved for extensive disease or abscess formation.
Nocardia is an unusual aerobic actinomycetic infection that can
involve several organ systems. In view of their hyphal morphology,
Nocardia were once classiﬁed as fungi: lately molecular analysis of
their cell walls has enabled their reclassiﬁcation as bacteria.
Although they have a propensity to involve the lung, skin, and
brain, Nocardiae can disseminate to virtually any organ in the body.
Since Nocardiae probably also exist as L-forms (cell wall deﬁcient
variants), infection can relapse years after apparently successful
treatment.5 Nocardiae are found worldwide, in soil, aquatic bodies
and in decaying organic matter. To date at least sixteen species
capable of producing disease in humans have been identiﬁed.6
Among implicated risk factors are: chronic therapy with
glucocorticoids,7 obstructive lung disease, autoimmune disease,
malignancy8 diabetes and alcoholism,9 chronic granulomatous
disease,10 alveolar proteinosis and usage of tumor necrosis factor
antagonists such as inﬂiximab. The disease is relatively unusual in
Acquired Immunodeﬁciency Syndrome (AIDS) patients, presum-
ably because of TMPeSMX prophylaxis that these patients
receive.11 Nevertheless in spite of TMPeSMX prophylaxis, organ
transplant patients receiving high-grade immunosuppression are
particularly prone to develop Nocardial disease.12As in the case of this patient, the disease can occur frequently in
the apparently immunocompetent. As many as 36% of all Nocardial
infections have been shown to occur in individuals in whom no
obvious immunodeﬁciency was identiﬁed.5 The vast majority (two
thirds) of all cases affect the lungs,9 in keeping with the commonest
mode of transmission, inhalation.13 Direct inoculation across skin
surfaces by thorn-pricks, trauma, and even nosocomial breaches of
skin and mucosal surfaces by catheters and surgical procedures can
result in disease.14,15
Pulmonary Nocardiosis can present with a wide spectrum of
radiologic ﬁndings; solitary or multiple pulmonary nodules,
masses, cavities, reticulonodular or airspace inﬁltrates, pleural
effusions and subpleural plaques can all occur. Since upper lobe
lesions are common it is not unusual to see patients receive several
weeks of anti-tubercular therapy before appropriate treatment is
begun (in one study the mean period between the onset of symp-
toms and diagnosis was twelve months).16 The key to diagnosis is
a high index of suspicion in a patient with a non-resolving pleural
or pulmonary pathology with the above-mentioned co-morbid-
ities; or a lung pathology that is associated with brain (Nocardia has
a special afﬁnity for the CNS), skin or other soft tissue lesions. A
diagnostic intervention in the setting of an unknown lesion often
provides the ﬁrst clue.16 Nocardiae are not normal colonials of the
tracheobronchial tree, and therefore a sputum isolate of Nocardia is
almost always signiﬁcant.17 The visualization of the characteristic
delicate acid-fast ﬁlamentous rods enables a presumptive diagnosis
to be made. Since Nocardia takes 1e3 weeks to grow out of culture
the lab must be forewarned so that specimens are retained for this
period.18 The response of different Nocardial species to antibiotics
may vary, so antibiotic sensitivity testing is routinely recom-
mended. Sulphonamides form the cornerstone of therapy. In most
forms of the disease treatment is given for 3e12 months. Typically,
serious lung infections are treated for 6e12 months. Immunosup-
pressed patients are routinely treated for at least a year and should
be considered for lifelong suppressive therapy.19
This case is a good example of the co-occurence of lipoid
pneumonia with M. fortuitumdboth of which seem to have an
afﬁnity for lipid milieu. It is also unique in that the Nocardial
superinfection presented in an immunocompetent individual.
4. Conclusion
Lipoid pneumonia should be considered as the diagnosis in the
setting of non-resolving pneumonia associated with oil instillation
(as nasal drops, liquid parafﬁn, etc). A high index of suspicion
should be maintained for the existence of a second pathology such
as a Mycobacterial or Nocardial infection, and wherever possible
microbiological stains and cultures should be done in addition to
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